Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
Sales | 3,554 | 4,101 | 5,761 | 4,210 | 12,221 |
Gross Profit | 3,554 | 4,101 | 5,761 | 4,210 | 12,221 |
Operating Expenses | 8,870 | 14,796 | 13,777 | 14,386 | 17,222 |
Operating Income | -5,316 | -10,695 | -8,016 | -10,176 | -5,001 |
Interest Expense | 1,180 | 1,180 | 1,166 | 1,160 | 1,160 |
Other Income | 1,990 | 822 | -518 | -940 | 109 |
Pre-tax Income | -4,506 | -11,053 | -9,700 | -12,276 | -6,052 |
Net Income Continuous | -4,506 | -11,053 | -9,700 | -12,276 | -6,052 |
Net Income | $-4,506 | $-11,053 | $-9,700 | $-12,276 | $-6,052 |
EPS Basic Total Ops | -0.09 | -0.22 | -0.19 | -0.25 | -0.13 |
EPS Basic Continuous Ops | -0.09 | -0.22 | -0.19 | -0.25 | -0.13 |
EPS Diluted Total Ops | -0.09 | -0.22 | -0.19 | -0.25 | -0.13 |
EPS Diluted Continuous Ops | -0.09 | -0.22 | -0.19 | -0.25 | -0.13 |
EBITDA(a) | $-5,109 | $-10,418 | $-7,771 | $-9,909 | $-4,723 |